CLINICAL_TRIALS
trial_result
· 2021-03-04
Clinical Trial Update: A Controlled Trial of Erenumab in Migraine Prevention [Phase 3]
Summary
Phase 3 trial results for erenumab in migraine prevention have completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2021-03-04